首页>Pharmacoepidemiology and drug safety>Is Sodium Valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study
Is Sodium Valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study
作者单位：Department of Primary Care and Public Health Sciences, King's College London, London, United Kingdom[1]Department of Primary Care and Public Health Sciences, King's College London, London, United[2]Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge[3]
换一批
